Recent Articles from GlobeNewswire

EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in May.

Advances Nanox’s ongoing U.S. commercialization and deployment efforts

Establishes Pittsburgh headquarters to support U.S. market expansion and SOLO™ deployment

Hong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (“Mint” or the “Company”, NASDAQ: MIMI), a Hong Kong-based company with a new strategic focus on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider, announces that it is implementing a reverse stock split of all of the Company's issued and unissued shares, including the Class A ordinary shares with no par value (the "Class A Ordinary Shares") and Class B ordinary shares with no par value (the “Class B Ordinary Shares,” together with the Class A Ordinary Shares, the "Ordinary Shares"), at an exchange ratio of one (1) share for ten (10) shares (the “Reverse Stock Split”). The Reverse Stock Split was approved by the Company’s Board of Directors on March 31, 2026.

For Immediate ReleaseNews Release

Oral presentation includes early readouts from preclinical testing of CAR-encoding episomal DNA delivered by targeted lipid nanoparticles

Vancouver, BC , May 04, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it has filed its audited annual financial statements for the fiscal year and fourth quarter ended December 31, 2025. The Company’s financial statements and Management’s Discussion and Analysis (“MD&A”) are available under its profile on SEDAR+ at www.sedarplus.ca.

New recognition program and proprietary research highlight how solopreneurs are using AI to replace traditional team functions and build scalable, independent businesses

-- Pediatric patients (n=10) with acquired hypothalamic obesity achieved sustained reductions in BMI and BMI-Z at 2.5 years of setmelanotide therapy ---- Weight category improvements observed in pediatric patients with acquired hypothalamic obesity treated with setmelanotide --

Ahold Delhaize USA Brands’ Nearly 2,000 stores Now Available on Uber Eats Marketplace for On-Demand Delivery

First Wave of a Multi-Year, Multi-Format Retail Digitalization

Six-month data from adult Cohort 4 show structural and functional improvements and a favorable safety profile; early safety data from pediatric Cohort 5 are consistent with adult cohorts

GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global diabetes community, announced that it has entered into a Second Amendment to the Loan and Security Agreement with Hercules Capital, Inc. (NYSE: HTGC). The Second Amendment increases the maximum borrowing capacity under the existing facility from $100 million to $140 million.

Praxis executes complete, AI-powered workflows end-to-end, turning enterprise operations into a self-improving intelligence engine.

Global data since 2013 show just 3% lifetime fracture prevalence, declining to 0.3% over the past six years

Peer-reviewed research by General Fusion and Savannah River National Laboratory supports the tritium supply advantages of General Fusion’s practical Magnetized Target Fusion technology

Ms. Dac brings more than 30 years of experience successfully executing product launches and scaling commercial organizations for a range of therapeutic areas

Leading experts across cell therapy, oncology, and immunology will provide strategic input as Legend advances and expands beyond its current portfolio

Brings Total Capital Raised Across Accord Dislocation Complex to $11.6 Billion Since Inception

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the Annual General Meeting (AGM) of Shareholders will take place on Tuesday, June 2, 2026 at 1500 CEST at the offices of Allen Overy Shearman Sterling LLP, in Amsterdam, the Netherlands.

Grapevine, TX, May 04, 2026 (GLOBE NEWSWIRE) -- This May the Fourth, popularly called Star Wars Day, Patriot Mobile is calling on Americans to “use the Force” for good – announcing its growth as a company is enabling an even greater commitment to supporting faith, family, and freedom-focused initiatives nationwide.

FREIBURG, Germany and ROSCREA, Ireland, May 04, 2026 (GLOBE NEWSWIRE) -- Dr. Falk Pharma GmbH (“Dr. Falk Pharma”), a research-based pharmaceutical company specializing in digestive and metabolic medicine, and Renexxion Ireland Limited (“Renexxion”), a clinical-stage biopharmaceutical company, today announced positive results from MOVE-IT (NCT05621811), a global Phase 2b, randomized placebo-controlled trial evaluating the efficacy, safety, and tolerability of naronapride in adults with gastroparesis.

America’s No. 1 family entertainment brand, named a Newsweek America’s Greatest Workplace for Entry Level 2026, targets 3,200 new Cast Members this summer

New solution expands RILA access with additional buffer options, helps streamline product selection and delivers greater control

MAPLE GROVE, Minn., May 04, 2026 (GLOBE NEWSWIRE) -- EarthDaily Analytics (EarthDaily) today announced the successful launch of six EarthDaily Constellation satellites aboard a SpaceX Falcon 9 rideshare mission, confirming initial contact with satellites EDC-02 through EDC-07. The milestone significantly advances the company’s goal of delivering daily, consistent measurement of planetary change at global scale.

PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today upcoming presentations, including one late-breaking oral presentation, of new data from the Phase 3 ATTRibute-CM study in individuals with transthyretin amyloid cardiomyopathy (ATTR-CM) at Heart Failure 2026, organized by the Heart Failure Association of the European Society of Cardiology (ESC-HF), taking place in Barcelona, Spain on May 9-12, 2026.

HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Fervo Energy (“Fervo” or the “Company”) today announced the launch of the Company’s roadshow for its initial public offering (“IPO”) of 55,555,555 shares of its Class A common stock. The IPO price is expected to be between $21.00 to $24.00 per share. Additionally, Fervo expects to grant the underwriters a 30-day option to purchase up to an additional 8,333,333 shares of the Company’s Class A common stock. Fervo has applied to list its Class A common stock on the Nasdaq, subject to official notice of issuance, under the ticker symbol “FRVO.”

Clinically significant angiokeratomas represent a rare, chronic and debilitating lymphatic malformation with no FDA-approved therapies and an estimated more than 50,000 diagnosed patients in the U.S.

This substantially de-leverages the balance sheet with minimal remaining liabilities

Shelton, CT, May 04, 2026 (GLOBE NEWSWIRE) --

Multi-Year Agreement Extends Rekor as the Engine Behind One of the Nation's Most Successful Uninsured Motorist Reduction Programs

BRISBANE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will present at the Bank of America Securities 2026 Health Care Conference, which is taking place in Las Vegas, NV from May 12-14, 2026. The management team will also participate in one-on-one investor meetings.

TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced that the Company will release its financial and operating results for the first quarter of 2026 prior to the market open on Thursday, May 14, 2026, Eastern Time (“ET”). The Company will then host a conference call to review the results later that day, at 2:00 pm ET. Those wishing to join the call can do so using the telephone numbers listed below. The call will also be webcast and available on the Company’s website at www.discoverysilver.com.

• MacroGenics receives $60 million cash payment from Sagard Healthcare Partners (Sagard), with the potential to receive an additional near-term sales-based milestone of up to $20 million

Owners Kiran Mantripragada and Uday Kiran Namballa Anchors Franchise; Active Discussions With Sri Lankan Marquees Dasun Shanaka and Eshan Malinga Ahead of July–August 2026 Tournament Window

BELTSVILLE, Md., May 04, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer and Simcere Zaiming Pharmaceutical Co., Ltd., (Simcere) an oncology-focused biopharmaceutical company and a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096), today announced initiation of the dose optimization portion of the Phase 1 study of SIM0505, focusing on patients with platinum-resistant ovarian cancer. SIM0505 is an investigational antibody drug conjugate (ADC) comprised of an antibody that targets Cadherin-6 (CDH6) and a proprietary topoisomerase 1 inhibitor (TOPOi) payload.

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH) plans to report first quarter 2026 results on Tuesday, May 12, 2026. Management will present results during a conference call at 8:30 a.m. Eastern time.

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”) and an affiliate have provided a first lien senior secured term loan and a preferred equity investment in Security Fire Systems (“SFS”), aggregating approximately $26 million, in collaboration with Blackford Capital.

Represents achievement of strategic milestone for Cibus’ anticipated first commercial offering in the South American market

PENSACOLA, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Advanced Technology Recycling (ATR), a leading IT Asset Management and Electronics Refurbishment company, is pleased to announce that we are now offering wholesale electronics to the general public through our online auction site. 

Total 1Q 2026 net product revenue of $191.2 million, representing 57% year-over-year growth

RAMSEY, N.J. and BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced the U.S. Food and Drug Administration (“FDA”) has approved the Company’s supplemental Biologics License Application (BLA) submitted under section 351(a) of the Public Health Service Act for ASCENIV™. The FDA approval represents the final study report for the Pediatric assessment as required in the post marketing commitment.

OAK CREEK, Wis., May 04, 2026 (GLOBE NEWSWIRE) -- The Oak Creek-Franklin Joint School District (OCF) has announced a new partnership with Edustaff, a leading provider of educational staffing services, to enhance the district’s ability to recruit, place, and retain high-quality substitute teachers, paraprofessionals, and support staff across its schools. The collaboration is designed to ensure continuity of instruction and student support throughout the academic year.

SAN JOSE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that it will release results for the first quarter ended March 31, 2026 on Thursday, May 14, 2026, prior to the market open.  

Ghent, Belgium, 4 May 2026 – Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and commercial reach globally.

CHICAGO and VANCOUVER, British Columbia, May 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced that it has submitted applications to the U.S. Drug Enforcement Administration (“DEA”) to register certain state-licensed medical cannabis operations under the expedited registration pathway created in connection with the recent rescheduling of medical marijuana to Schedule III of the Controlled Substances Act.

RICHMOND, Va., May 04, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), today announced that it has entered into a $175 million accelerated share repurchase agreement (“the ASR”) with Barclays Bank PLC (“Barclays”). The ASR will be executed under Indivior’s existing $400 million share repurchase program previously authorized by the Company’s Board of Directors. The ASR reflects the Company’s confidence in its long-term strategy, cash flow generation, and commitment to disciplined capital allocation.

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced FORTE MINERALS CORP. (CSE: CUAU; OTCQX: FOMNF), a Canadian exploration company, has qualified to trade on the OTCQX® Best Market. FORTE MINERALS CORP. upgraded to OTCQX from the OTCQB® Venture Market.

Partnership expands Istios Health’s multi-specialty research platform, enhances infectious disease capabilities, and broadens access to innovative therapies for patients and life sciences partners

SAN FRANCISCO, May 04, 2026 (GLOBE NEWSWIRE) -- Genyro, a San Diego-based biotechnology company advancing next-generation DNA construction, announced significant new data just published on bioRxiv that will be discussed at SynBioBeta in San Francisco. The data details new developments in Genyro’s breakthrough DNA construction invention, Sidewinder, recently published in Nature, which achieves first-of-its-kind realization of scalable, parallel DNA construction that overcomes the cost, time, and accuracy constraints of existing methods and opens the door to scalable AI-facilitated DNA design.

Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph® Product Suite

First-of-its-kind Functional Non-Alcoholic Cocktail Meets Crushable, Low-Sugar Vodka Refresher - Both Crafted with Real Fruit Juice and a Pinch of Oregon Coast Sea Salt

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group (OTCQX: OTCM), operator of regulated markets for more than 12,000 U.S. and international securities, today announced the appointment of JP Chan as Senior Vice President and Regional Head, Asia-Pacific. Chan will lead OTC Markets’ regional team out of Hong Kong, overseeing Asia-Pacific, and working with issuers, market participants and investors to efficiently access US capital markets via OTC Markets Group.

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (Nasdaq: MWH) (“SOLV”), a leading provider of infrastructure services to the power industry, today announced it has entered into an agreement to acquire Roberson Waite Electric (“RWE”), a California-based provider of utility substation construction, testing, commissioning, and related infrastructure services.

WATERLOO, Ontario and ATLANTA, May 04, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its first quarter fiscal 2027 financial results after market close on Wednesday, June 03, 2026.

LEWISVILLE, TEXAS, May 04, 2026 (GLOBE NEWSWIRE) -- LEWISVILLE, TEXAS, May 4, 2026 – GMR Solutions Inc. (“GMR”) today announced the launch of its initial public offering of 31,914,893 shares of its Class A common stock. The initial public offering price for the Class A common stock is expected to be between $22.00 and $25.00 per share.

PHILADELPHIA, May 04, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases, announced today the pricing of an underwritten offering of 51,725,000 shares of common stock. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $150 million. The offering is expected to close on or about May 5, 2026, subject to the satisfaction of customary closing conditions. The financing included participation from Bain Capital Life Sciences, Adage Capital Management, Cormorant Asset Management and other existing investors, multiple new mutual and sovereign wealth funds and Eli Lilly and Company.

BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (“ADT” or the “Company”) today announced a proposed secondary public offering of 102,000,366 shares of the Company’s common stock held by certain entities managed by affiliates of Apollo Global Management, Inc. (the “Selling Stockholders”), which represent all the remaining shares owned by the Selling Stockholders. The Company is not selling any shares and will not receive any proceeds from the proposed offering.

CHANTILLY, Va., May 04, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) has been awarded a contract by The Boring Company (TBC) to provide professional services in support of the Dubai Loop project, an underground transportation initiative being developed in Dubai, United Arab Emirates. This 9-month contract represents new work for Parsons.

Near-total warrant participation strengthens the treasury and reinforces investor confidence as the Company accelerates global commercialization of the NVRO Process™

Accelerates Transition to SHOP-Dominant Overall Portfolio and Strengthens Balance Sheet

HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today its Mission Technology Solutions division was awarded two task order modifications with a combined ceiling of $449 million to continue providing intelligent, data-driven logistics support to the U.S. Army in Europe and North America. The Army Contracting Command awarded these task order modifications under the Logistics Civil Augmentation Program (LOGCAP) V contract.

MACAU, May 04, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment published its 2025 Sustainability Report, titled “RISE to Go Above & Beyond”. The report outlines the Company’s significant developments in environmental stewardship, community engagement, and transparent corporate governance.

From May 3-6, ACT members will hold meetings with Members of Congress, Senators, Administration officials and staff

DUBLIN, May 04, 2026 (GLOBE NEWSWIRE) -- For IT teams, one of the biggest risks when an employee travels is not the flight itself, but what happens upon arrival: landing without reliable internet access. This goes far beyond lost time, as it often translates into lack of access to critical tools, reliance on unsecured public WiFi networks, and decisions being made without real-time information.

CERRITOS, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean BBQ, a fast-growing casual dining concept with an extensive menu and signature “grill at your table” experience, today announced the continued product placement of its CPG products, including the adult beverages Soju, with number one beverage retailer on the west coast, BEVMO.

EBENE, Mauritius, May 04, 2026 (GLOBE NEWSWIRE) -- As the world prepares for the most anticipated sporting event on the planet, PU Prime, a leading global brokerage and regional sponsor of the Argentine Football Association (AFA), is proud to announce the launch of the “PU World Cup 2026” campaign. This initiative represents a strategic convergence of market precision and athletic excellence, celebrating the shared values of strategy, discipline, and the pursuit of "The Glory" on a global stage.

Session featuring CD Projekt Red, Supercell, Ubisoft, and Think Influence will explore how gaming brands are redefining entertainment through licensing and cultural innovation, in a panel moderated by Game Developer

The U.S. Pavilion will host an opening event on Wednesday, May 6 at 11 a.m., during the Biennale’s official opening week in Venice, inaugurating the 2026 exhibition curated by Jeffrey Uslip

LIDKÖPING, Sweden, May 04, 2026 (GLOBE NEWSWIRE) -- ASKO, the Swedish brand synonymous with high-end Scandinavian design and professional-grade performance, has expanded its innovative Celsius built-in oven range with the addition of the Elements series. This new line has already been recognised for its excellence, winning the prestigious iF Design Award 2026. The oven was presented at ASKO’s stand at EuroCucina and in the ASKO pop-up showroom at Via Alessandro Manzoni 39 in the Brera district, as part of the brand’s collaboration with design studio Draga and Aurel. Presented alongside renowned Chef Wilfred Hoquet and ASKO’s Brand Chef Tim Delissen, the new oven captivated audiences with its exceptional versatility, precision, and performance.

ZURICH-SCHLIEREN, Switzerland and Concord, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics, today announced its attendance and presentations on its lead Radio-DARPin candidate MP0712 at upcoming scientific conferences.

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) --

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) --